MétaCan
Menu
Back to cohort
Record W2765239123 · doi:10.1016/j.conctc.2017.11.001

Bayesian adaptive clinical trials of combination treatments

2017· article· en· W2765239123 on OpenAlexaff
Kristian Thorlund, Shirin Golchi, Edward J. Mills

Bibliographic record

VenueContemporary Clinical Trials Communications · 2017
Typearticle
Languageen
FieldMathematics
TopicStatistical Methods in Clinical Trials
Canadian institutionsSimon Fraser UniversityMcMaster UniversityImpact
Fundersnot available
KeywordsBayesian probabilityClinical trialComputer scienceEconometricsMedicineArtificial intelligenceMathematicsInternal medicine

Abstract

fetched live from OpenAlex

Randomized clinical trials (RCT) increasingly investigate combination therapies. Strong biological rationale or early clinical evidence commonly suggest that the effect of the combination treatment is importantly greater than the maximum effect of any of the individual treatments. While these relationships are commonly well-accepted, RCTs do not incorporate them into the design or analysis plans. We therefore propose a simple Bayesian framework for incorporating the known relationships that the effectiveness of a combination treatment exceeds that of any individual treatment, but does not necessarily exceed the sum of individual effects. We term the collation of these two relationships ‘fractional additivity’. We performed a binary outcome simulation study of a response adaptive randomized three-arm clinical trial with treatment arms A, B, and A&B that allowed for dropping an inferior treatment arm and terminating the trial early for superiority during any of 4 interim analyses. We compared the Bayesian fractional additivity model to a conventional analysis by measuring the expected proportion of failures, sample size at trial termination, time to termination, and root mean squared error of final estimates. We also compared the fractional additivity model to a ‘full additivity’ model where the effect of A&B was assumed to be the sum of the effect of A and B. In simulation scenarios where important fractional additivity or full additivity existed, the Bayesian fractional additivity model yielded a 3–4% relative reduction in expected number of failures, and a 30%–50% relative reduction in sample size at trial termination compared to a conventional analysis. These results held true even when the Bayesian fractional additivity model employed a biased prior. The full additivity model had slightly higher gains, but too frequently terminated the trial at the first interim look. In scenarios where no or weak fractional additivity exists, the expected sample size and time to termination were similar for the Bayesian fractional additivity model with a moderately optimistic bias about fractional additivity and the conventional model. Lastly, the fractional additivity model generally yielded similar or lower root mean squared error compared to the other models. In conclusion, our proposed Bayesian fractional additivity model provides an efficient approach for estimating effects of combination treatments in clinical trials. The approach is not only highly applicable in adaptive clinical trials, but also provides added power in a conventional RCT.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.168
metaresearch head score (Gemma)0.343
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Theoretical or conceptual · Consensus signal: none
GenreCandidate signal: Methods · Consensus signal: Methods
Teacher disagreement score0.168
Threshold uncertainty score0.887

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1680.343
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0040.003
Bibliometrics0.0020.001
Science and technology studies0.0010.005
Scholarly communication0.0030.006
Open science0.0040.004
Research integrity0.0040.006
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.966
GPT teacher head0.744
Teacher spread0.223 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designTheoretical or conceptual
Domainnot available
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations7
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueContemporary Clinical Trials CommunicationsSame topicStatistical Methods in Clinical TrialsFrench-language works237,207